当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析

华恒生物

(688639)

  

流通市值:70.73亿  总市值:70.73亿
流通股本:2.50亿   总股本:2.50亿

华恒生物(688639)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.38亿元,每股收益0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益266885.27万元,未分配利润117982.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产602591.43万元,负债335706.17万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入771,264,504.422,861,841,123.692,193,542,266.711,489,160,461.14
营业总成本736,379,623.792,744,165,757.742,022,179,740.121,361,608,565.23
其他经营收益
营业利润38,412,949.18129,653,437.59174,450,674.85121,375,747.13
利润总额35,904,588.5125,557,074.99171,328,066.51118,568,919.64
净利润37,525,795.77123,861,236.18159,424,732.82109,148,765.67
每股收益
其他综合收益-532,923.39-532,114.32-253,721.72-78,859.73
综合收益总额36,992,872.38123,329,121.86159,171,011.1109,069,905.94
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,732,214,300.611,464,083,098.231,654,263,099.651,452,801,954.17
非流动资产:
非流动资产合计4,293,700,031.814,310,598,381.224,017,402,181.773,848,819,905.4
资产总计6,025,914,332.425,774,681,479.455,671,665,281.425,301,621,859.57
流动负债:
流动负债合计1,427,779,917.221,339,322,141.971,145,168,292.321,328,312,593.03
非流动负债:
非流动负债合计1,929,281,756.21,803,499,550.861,858,795,313.241,355,708,695.84
负债合计3,357,061,673.423,142,821,692.833,003,963,605.562,684,021,288.87
所有者权益(或股东权益):
归属于母公司股东权益合计2,688,246,517.272,646,682,105.352,682,169,896.032,629,615,367.51
股东权益合计2,668,852,6592,631,859,786.622,667,701,675.862,617,600,570.7
负债和股东权益合计6,025,914,332.425,774,681,479.455,671,665,281.425,301,621,859.57
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计816,800,729.152,870,866,338.292,252,920,988.181,492,091,877.78
经营活动现金流出小计803,728,355.822,766,319,667.22,138,179,477.181,417,360,182.02
经营活动产生的现金流量净额13,072,373.33104,546,671.09114,741,51174,731,695.76
投资活动产生的现金流量:
投资活动现金流入小计-2,087,534.5137,856.717,558.7
投资活动现金流出小计171,340,742.42645,543,403404,489,353.24261,450,489.31
投资活动产生的现金流量净额-171,340,742.42-643,455,868.49-404,451,496.54-261,432,930.61
筹资活动产生的现金流量:
筹资活动现金流入小计667,003,401.881,722,983,807.071,458,093,321.39797,283,387.65
筹资活动现金流出小计343,403,598.961,313,764,434.961,092,135,582.08647,734,465.18
筹资活动产生的现金流量净额323,599,802.92409,219,372.11365,957,739.31149,548,922.47
汇率变动对现金及现金等价物的影响-3,274,039.73-1,147,319.181,745,348.31,463,668.06
现金及现金等价物净增加额162,057,394.1-130,837,144.4777,993,102.07-35,688,644.32
期末现金及现金等价物余额446,179,600.53284,122,206.43492,952,452.97379,270,706.58
补充资料:
现金及现金等价物的净增加额--130,837,144.47--35,688,644.32
最新报告期:2026-04-14
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
天风证券唐婕,邢颜凝1.271.732.282026-04-14
长江证券王呈,马太,魏凯1.441.932.052026-03-29
申万宏源周超,宋涛0.931.391.962026-03-24
中金公司裘孝锋1.081.48--2026-03-19
TOP↑